OrbiMed Capital GP VII LLC

10% OwnerPassage BIO, Inc. (PASG) · full profile →Form 4 · filed Apr 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2025Sell(S)77K$0.33$25K6.9M
Apr 16, 2025Sell(S)62K$0.33$20K7.0M
Apr 15, 2025Sell(S)10K$0.38$4K7.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000415) within minutes of acceptance. Every field above traces to the original document. Verify it directly: